Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature
- Author
- Willeke Danckaert (UGent) , Mathieu Spaas (UGent) , Katrien Vandecasteele (UGent) , Carlos De Wagter (UGent) and Piet Ost (UGent)
- Organization
- Keywords
- BONE-MARROW REGENERATION, RADIATION-THERAPY, HEMATOLOGIC TOXICITY, CANCER-PATIENTS, LYMPHOCYTES, IRRADIATION, SURVIVAL, VOLUME, IMMUNOTHERAPY, OUTCOMES, Radiotherapy, Dosimetry, Lymphopenia, Lymphocyte count, Urologic, neoplasms
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 383.43 KB
-
Carlos Wagter et al Accepted Manuscript.pdf
- full text (Accepted manuscript)
- |
- open access
- |
- |
- 223.77 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8763316
- MLA
- Danckaert, Willeke, et al. “Impact of Radiotherapy Parameters on the Risk of Lymphopenia in Urological Tumors : A Systematic Review of the Literature.” RADIOTHERAPY AND ONCOLOGY, vol. 170, 2022, pp. 64–69, doi:10.1016/j.radonc.2022.02.030.
- APA
- Danckaert, W., Spaas, M., Vandecasteele, K., De Wagter, C., & Ost, P. (2022). Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature. RADIOTHERAPY AND ONCOLOGY, 170, 64–69. https://doi.org/10.1016/j.radonc.2022.02.030
- Chicago author-date
- Danckaert, Willeke, Mathieu Spaas, Katrien Vandecasteele, Carlos De Wagter, and Piet Ost. 2022. “Impact of Radiotherapy Parameters on the Risk of Lymphopenia in Urological Tumors : A Systematic Review of the Literature.” RADIOTHERAPY AND ONCOLOGY 170: 64–69. https://doi.org/10.1016/j.radonc.2022.02.030.
- Chicago author-date (all authors)
- Danckaert, Willeke, Mathieu Spaas, Katrien Vandecasteele, Carlos De Wagter, and Piet Ost. 2022. “Impact of Radiotherapy Parameters on the Risk of Lymphopenia in Urological Tumors : A Systematic Review of the Literature.” RADIOTHERAPY AND ONCOLOGY 170: 64–69. doi:10.1016/j.radonc.2022.02.030.
- Vancouver
- 1.Danckaert W, Spaas M, Vandecasteele K, De Wagter C, Ost P. Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature. RADIOTHERAPY AND ONCOLOGY. 2022;170:64–9.
- IEEE
- [1]W. Danckaert, M. Spaas, K. Vandecasteele, C. De Wagter, and P. Ost, “Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature,” RADIOTHERAPY AND ONCOLOGY, vol. 170, pp. 64–69, 2022.
@article{8763316,
author = {{Danckaert, Willeke and Spaas, Mathieu and Vandecasteele, Katrien and De Wagter, Carlos and Ost, Piet}},
issn = {{0167-8140}},
journal = {{RADIOTHERAPY AND ONCOLOGY}},
keywords = {{BONE-MARROW REGENERATION,RADIATION-THERAPY,HEMATOLOGIC TOXICITY,CANCER-PATIENTS,LYMPHOCYTES,IRRADIATION,SURVIVAL,VOLUME,IMMUNOTHERAPY,OUTCOMES,Radiotherapy,Dosimetry,Lymphopenia,Lymphocyte count,Urologic,neoplasms}},
language = {{eng}},
pages = {{64--69}},
title = {{Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature}},
url = {{http://doi.org/10.1016/j.radonc.2022.02.030}},
volume = {{170}},
year = {{2022}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: